Prostate test 'public health disaster': discoverer (Reuters)
Reuters - The most commonly used tool for detecting prostate cancer, routine PSA screening, has become "a hugely expensive public health disaster," its discoverer said on Wednesday.
Scientists Find Key to Hormone-Resistant Prostate Tumors (HealthDay)
HealthDay - WEDNESDAY, March 10 (HealthDay News) -- Though hormone therapy has proven useful in treating late-stage prostate cancer, it often results in the development of fatal secondary tumors that are resistant to such therapy.
Doctor's Specialty Often Steers Prostate Cancer Care (HealthDay)
HealthDay - TUESDAY, March 9 (HealthDay News) -- The kind of treatment received by a prostate cancer patient often depends on the type of specialist providing the patient's care, new research shows.
Specialty may bias doctors' prostate cancer advice (Reuters)
Reuters - New research suggests that the type of specialist a prostate cancer patient sees -- rather than the patient's own preference -- may determine the treatment he receives.
New Prostate Cancer Guidelines Aim to Empower the Patient (HealthDay)
HealthDay - FRIDAY, March 5 (HealthDay News) -- New American Cancer Society guidelines on prostate cancer screening mean that many men will be faced with a cascade of decisions, with a growing responsibility for those decisions falling on their shoulders.
New Drugs, Approaches Offer Hope Against Prostate Cancer (HealthDay)
HealthDay - WEDNESDAY, March 3 (HealthDay News) -- Scientists are making headway in finding ways to treat and detect stubborn forms of prostate cancer.
Cancer society casts more doubt on prostate tests (AP)
AP - Months after experts discounted the importance of routine mammograms and Pap smears for many women, the American Cancer Society is warning more explicitly than ever that regular testing for prostate cancer is of questionable value too, and can do men more harm than good.
New Prostate Cancer Screening Guidelines Unveiled (HealthDay)
HealthDay - WEDNESDAY, March 3 (HealthDay News) -- For the first time in almost a decade, the American Cancer Society has revamped its recommendations for prostate cancer screening.
Sanofi drug shows promise against prostate cancer (AP)
AP - For the first time, an experimental drug has extended the lives of men with advanced prostate cancer who are no longer responding to other treatments and are out of options for fighting the disease, a company-led study found.
Should men be tested for prostate cancer? (AP)
AP - The American Cancer Society revised its guidelines for prostate cancer screening on Wednesday. The advocacy group is one of many organizations that make such recommendations. Some questions and answers:
Websrv_120_1